Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2026-02-01 @ 1:03 PM
Study NCT ID:
NCT03441061
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-13
First Post:
2018-02-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
Sponsor:
M.D. Anderson Cancer Center
Organization: